SYSeher Yılmaz

Seher Yılmaz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Seher Yılmaz has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • İşitsel Rehabilitasyonda Kavramsal Çerçeve ve Temel Değerlendirme Süreçleri

    by Seher Yılmaz

    İşitsel rehabilitasyon; işitme kaybının bilişsel, sosyo-duygusal ve toplumsal işlevsellik üzerindeki çok boyutlu etkilerini bütüncül bir perspektifle ele alan dinamik bir müdahale alanıdır. Bu bölümde kavramsal çerçeve WHO'nun ICF modeli temel alınarak incelenmiş; Boothroyd'un dört temel bileşeni —duyusal yönetim, bilgilendirme, işitsel eğitim ve danışmanlık— ile Erber'in işitsel algı hiyerarşisi açıklanmıştır. Etkili rehabilitasyonun titiz bir değerlendirme süreciyle başladığı ve kişi merkezli yaklaşımla anlam kazandığı vurgulanmıştır. Auditory rehabilitation is a dynamic intervention field that holistically addresses the multidimensional effects of hearing loss on cognitive, socio-emotional, and social functioning. This chapter examines the conceptual framework based on the WHO ICF model, explaining Boothroyd's four core components —sensory management, instruction, auditory training, and counseling— and Erber's auditory perception hierarchy. It is emphasized that effective rehabilitation begins with rigorous assessment and is shaped by a person-centered approach.

  • Güncel Kulak Burun Boğaz Hastalıkları Çalışmaları V

    by Yusuf Aydın, Leyla Türe, Deniz Tuz, Pelin Özcan Ulubeli, Deniz Akmeşe, Zeynep Karagül, Elif Karahan, Doğa Şen, Seher Yılmaz, Merve Torun Topçu, et al.

  • Open Access

    Effect of Pycnogenol® on Noise-Induced Hearing Loss in Rats

    by Seher Yılmaz, Caner Yatmaz, Furkan Büyükkal, Alev Cumbul, Işılay Öz, M. Bülent Şerbetçioğlu

    Background: This study aims to elucidate the potential protective effects of Pycnogenol® against noise-induced hearing (NIHL) loss in a rat model. Methods: This study employed a randomized controlled design to investigate the potential protective effects of Pycnogenol® against NIHL in a rat model. Twenty-five male Wistar albino rats were randomly assigned to 5 groups (n=5 per group): a control group receiving saline administration, a noise exposure group, a noise+saline receiving group, only Pycnogenol® receiving group, and finally, a Pycnogenol® treatment group receiving daily oral administration of Pycnogenol® at 40 mg/kg/day via gavage for 7 days following noise exposure. All groups were subjected to auditory brainstem response assessments at 4 time points: pre-exposure (baseline), post-exposure day 1, day 7, and day 21. Both noise exposure and the Pycnogenol® treatment groups were exposed to 4 kHz narrowband noise at 120 dB SPL for 4 hours. Following sacrifice, histological and immunohistochemical evaluations were conducted on cochlear tissues. Statistical analyses were performed using SPSS software version 25 to determine significant differences between groups and across time points. Results: Outcome of this research shows that the auditory brainstem response thresholds and cochlear morphology between the experimental and control groups are significantly different from each other, suggesting that Pycnogenol® may have the potential to prevent NIHL loss in rats. Conclusion: Pycnogenol® shows potential in protecting against NIHL. However, further research, particularly at the molecular level, is necessary to better understand its therapeutic mechanisms and its specific impact on auditory metabolic processes.